Fenix Innovation Group
Clinical trials sponsored by Fenix Innovation Group, explained in plain language.
-
Cannabis extract shows promise for rare genetic disorder in new trial
Symptom relief Not yet recruitingThis study tests a cannabis plant extract called NTI164, which has very low THC (the compound that causes a high), in 40 females aged 4-25 with Rett syndrome, a rare genetic condition causing severe physical and mental challenges. Participants will receive either NTI164 or a plac…
Phase: PHASE2, PHASE3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Could cannabis extract ease autism symptoms? new trial seeks answers
Symptom relief Not yet recruitingThis study tests whether a full-spectrum cannabis plant extract called NTI164 can help reduce core autism symptoms (like social challenges and repetitive behaviors) in children and young adults aged 6 to 25. About 98 participants will receive either NTI164 or a placebo for 16 wee…
Phase: PHASE3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC